Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesRosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): A multicentre, randomised, open-label trial
The Lancet - Early Online Publication, 06/09/09
Home PD et al. – Addition of rosiglitazone to glucose-lowering therapy in pts with type 2 diabetes is confirmed to increase risk of heart failure and of some fractures, mainly in women. Despite inconclusive data are about any possible effect on myocardial infarction, rosiglitazone does not increase risk of overall cardiovascular morbidity or mortality compared with standard glucose-lowering drugs.
Methods- Study of cardiovascular outcomes after addition of rosiglitazone to either metformin or sulfonylurea vs combination over 5—7 yr follow-up
- Assessment of comparative safety
- Multicentre, open-label trial of 4447 pts with type 2 diabetes on metformin or sulfonylurea monotherapy with mean hemoglobin A1c (HbA1c) of 7.9%
- Randomization to addition of rosiglitazone (n=2220) or combination of metformin and sulfonylurea (active control group, n=2227)
- Primary endpoint: cardiovascular hospitalization or cardiovascular death
- 321 pts in rosiglitazone group and 323 in active control group experienced primary outcome during mean 5.5-yr follow-up, meeting criterion of non-inferiority
- HR was 0.84 for cardiovascular death, 1.14 for myocardial infarction, and 0.72 for stroke
- Heart failure causing admission to hospital or death in 61 people in rosiglitazone group and 29 in active control group
- Upper and distal lower limb fracture rates increased mainly in women assigned to rosiglitazone
- Mean HbA1c lower in rosiglitazone vs control group at 5 yrs
Related Articles
Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin over Four-Years in Spite of Greater Weight Gain: Observations from ADOPT (A Diabetes Outcome Progression Trial)
Diabetes Care, 10/14/09
Relevance Score: 88%
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
Hepatology, 11/02/09
Relevance Score: 87%
Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus
Metabolism-Clinical and Experimental, 10/26/09
Relevance Score: 87%
Effects of Laropiprant, a Selective Prostaglandin D2 Receptor 1 Antagonist, on the Pharmacokinetics of Rosiglitazone
Cardiovascular Drug Reviews, 11/17/09
Relevance Score: 85%
Stretch Reduces Nephrin Expression via an Angiotensin II-AT1-dependent Mechanism in Human Podocytes: Effect of Rosiglitazone
American Journal of Physiology: Renal Physiology, 11/17/09
Relevance Score: 85%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Insulin Resistance and Metabolic Syndrome in the Pediatric Population
Metabolic Syndrome and Related Disorders, 12/08/09
Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
Diabetes, 12/08/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Pituitary, 12/08/09
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/07/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Today in Coronary Artery Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Adiponectin Multimers and ADIPOQ T45G in Coronary Artery Disease in Caribbean Type 2 Diabetic Subjects of African Descent
Obesity, 12/08/09
Acute Myocardial Infarction and Coronary Artery Bypass Grafting Outcomes in Specialty and General Hospitals: Analysis of State Inpatient Data
Health Services Research, 12/08/09
Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
JACC - Journal of the American College of Cardiology, 12/08/09
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Reliability of an external loop recorder for automatic recognition and transtelephonic ECG transmission of atrial fibrillation
Journal of Telemedicine and Telecare, 12/08/09
Premature Aortic Atherosclerosis in Systemic Lupus Erythematosus: A Controlled Transesophageal Echocardiographic Study
Journal of Rheumatology, 12/08/09
Value of Estimated Right Ventricular Filling Pressure in Predicting Cardiac Events in Chronic Pulmonary Arterial Hypertension
Journal of The American Society of Echocardiography, 12/08/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid
Journal of Allergy and Clinical Immunology, 12/08/09
Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma
Journal of Allergy and Clinical Immunology, 12/08/09
In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii
The Journal of Antibiotics, 12/08/09
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Dietary intake of trans fatty acids as a cardiovascular risk factor in a population of Italian teenagers
Cardiology in the Young, 12/07/09
Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease
Evidence-Based Medicine, 12/07/09
Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies
British Medical Journal, 12/07/09
Sponsor
Article Search
Sponsor